why is johnson and johnson stock down today

Does Johnson&Johnson stock pay a dividend?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ.". Johnson & Johnson declared a quarterly dividend on Thursday, October 18th. Johnson & Johnson (NYSE:JNJ) issued its earnings results on Tuesday, October, 16th.

What is the upside for Johnson&Johnson's stock?

On average, they anticipate Johnson & Johnson's stock price to reach $152.10 in the next twelve months. This suggests a possible upside of 17.7% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

What is the ticker symbol for Johnson&Johnson?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ." Who are Johnson & Johnson's major shareholders? Johnson & Johnson's stock is owned by many different institutional and retail investors.

What are Wall Street analysts'price targets for Johnson&Johnson's stock?

12 Wall Street analysts have issued 1-year price objectives for Johnson & Johnson's shares. Their predictions range from $140.00 to $169.00. On average, they anticipate Johnson & Johnson's stock price to reach $152.10 in the next twelve months.

See more

Is JNJ a good stock to buy now?

Expectations For 2022 The firm expects to earn $10.15-$10.35 per share on $94.8 billion to $95.8 billion in sales. For the year, JNJ stock analysts call for adjusted profit of $10.27 per share on $96.49 billion in sales. Both measures would climb less than 10% year over year.

Will JNJ stock go up?

Johnson & Johnson (NYSE:JNJ) The 17 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 187.00, with a high estimate of 215.00 and a low estimate of 173.00. The median estimate represents a +5.14% increase from the last price of 177.85.

Is Johnson and Johnson going out of business?

J&J itself isn't bankrupt—instead, it has split off a new unit essentially designed to go broke paying legal liabilities. It's part of a maneuver to deal with about 38,000 lawsuits, mostly filed by women who claim one of the company's oldest products, baby powder, causes ovarian cancer.

Is JNJ a strong buy?

JNJ's strong financial fundamentals and its market position make it a highly secure option, with its diversified segments that result in a minimized risk exposure for the company. I believe the stock is a strong buy, especially for investors seeking stability through a financially sustainable business model.

Is JNJ a Buy Sell or Hold?

For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows

Is JNJ overvalued?

On a relative basis, the company is fairly valued and on an absolute basis overvalued....About JNJ.SymbolLast Price% ChgJNJPost177.51 176.800.29% -0.40%Oct 26, 2021

What happens to JNJ stock after split?

19. Rachel Warren: If you currently own shares of Johnson & Johnson like I do, when the company splits, you will own shares of both Johnson & Johnson, the new pharmaceutical/medical device entity, as well as the new yet-to-be-named consumer health business.

Does Johnson & Johnson own Pfizer?

Johnson & Johnson announced yesterday that it was buying the Pfizer division, paying $16.6 billion to beat out several other bidders. Analysts said the move would make Johnson & Johnson the world's largest consumer health care company.

Who owns Johnson and Johnson now?

Key Takeaways. The top individual shareholder of Johnson and Johnson is executive chairman Alex Gorsky with 3.2 million shares. Joaquin Duato—J&J's chief executive officer—is the second-largest individual shareholder with one million shares.

Does JNJ increase dividend in 2022?

New Brunswick, N.J. (April 19, 2022) – Johnson & Johnson today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share.

Is Johnson and Johnson a good company?

Johnson & Johnson Named to Glassdoor's 2018 List of Best Places to Work Johnson & Johnson Named to Glassdoor's 2018 List of Best Places to Work. The company nabbed a top spot on the annual list—based entirely on positive reviews from its own employees.

Is PG a good stock to buy?

For this reason and more, P&G is arguably the best company in the Household Products industry. As a result, the stock has outperformed the market by a wide margin over the last year, and the company's brands are garnering a larger market share. P&G is also noted for performing well during market downturns.

What happened

So what

Shares of Johnson & Johnson (NYSE: JNJ) are down more than 2% as of 3:25 p.m. EDT Thursday as potential regulation for prescription drug prices becomes clearer.

Now what

Today, the U.S. Department of Health and Human Services released the Biden administration's plan to drive down costs. It supports allowing the federal government to negotiate drug prices in its Medicare program. That's the federal insurance program for people aged 65 and older. Medicare also includes younger people with disabilities.

The Motley Fool

Don't expect legislation soon. Politicians are still divided -- even Democrats, who largely support the goals of the proposal. For its part, a drug manufacturing trade group pointed to the insurance industry as missing from the list of targets for change.

9 cybersecurity stocks to watch amid Russia attacking Ukraine: analyst

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community.

Ukraine-Russia crisis won't stop Fed from jacking up interest rates: Goldman Sachs

Wall Street is keyed in on cybersecurity stocks amid Russia's invasion of Ukraine.

What are Johnson and Johnson products?

Goldman Sachs says the Federal Reserve won't be budged on its rate hiking ambitions by the developing Ukraine-Russia crisis.

Where is Johnson and Johnson located?

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands ; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

How much is Johnson and Johnson stock worth in 2021?

Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Read More.

What is a break in a horizontal trend?

The Johnson & Johnson stock price gained 0.40% on the last trading day (Friday, 9th Jul 2021), rising from $169.08 to $169.75. During the day the stock fluctuated 0.67% from a day low at $169.24 to a day high of $170.37. The price has risen in 7 of the last 10 days and is up by 3.91% over the past 2 weeks. Volume fell on the last day by -109 thousand shares and in total, 6 million shares were bought and sold for approximately $951.32 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

What are Johnson and Johnson products?

A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Where is Johnson and Johnson located?

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands ; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women’s health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Is the DOJ a criminal investigation?

Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Does Johnson & Johnson have asbestos?

Bloomberg claims the DOJ's inquiry is a criminal investigation and that a grand jury is examining documents related to claims that company officials knew about carcinogens in the products. Image source: Getty Images.

Is Johnson & Johnson still cheap?

And in December, Reuters reported that Johnson & Johnson knew for decades that its talcum powder products contained asbestos.

Can we expect growth from Johnson & Johnson?

Johnson & Johnson is still trading at a fairly cheap price. The Simply Wall St valuation model shows that the intrinsic value for the stock is $251.94, which is above what the market is valuing the company at the moment.

Key Takeaways

With profit expected to grow by 51% over the next couple of years, the future seems bright for Johnson & Johnson. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. The company is continually investing in CapEx and is focused on improving cash flows efficacy in the future.

Ownership

Release

Sales

Risks

• 11 brokerages have issued 1-year price targets for Johnson & Johnson's shares. Their forecasts range from $129.00 to $157.00. On average, they expect Johnson & Johnson's share price to reach $146.00 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

See more on marketbeat.com

Ratings

Reviews

Business